124 related articles for article (PubMed ID: 7059914)
1. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
Brenner DE; Harvey HA; Lipton A; Demers L
Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
[TBL] [Abstract][Full Text] [Related]
2. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
Robertson RP; Baylink DJ; Metz SA; Cummings KB
J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.
Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L
Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
[TBL] [Abstract][Full Text] [Related]
6. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
Gottleib S; Rude RK; Sharp CF; Singer FR
Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin.
Tashjian AH; Voelkel EF; Levine L
Prostaglandins; 1977 Aug; 14(2):309-17. PubMed ID: 897222
[TBL] [Abstract][Full Text] [Related]
8. [Hypercalcemia in large cell lymphoma. Possible role of prostaglandins E2 (author's transl)].
Boissonnas A; Khalifa P; Sereni D; Mathiot C; Vacher-Lavenu MC; Hornych A; Cremer GA; Laroche C
Ann Med Interne (Paris); 1982; 133(3):186-91. PubMed ID: 6954869
[TBL] [Abstract][Full Text] [Related]
9. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
10. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
12. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
Uchida T; Kuwao S; Ishibashi A; Koshiba K
J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
[No Abstract] [Full Text] [Related]
13. Control of renal hemodynamics and glomerular filtration rate in chronic hypercalcemia. Role of prostaglandins, renin-angiotensin system, and calcium.
Levi M; Ellis MA; Berl T
J Clin Invest; 1983 Jun; 71(6):1624-32. PubMed ID: 6345587
[TBL] [Abstract][Full Text] [Related]
14. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?
Wallace LB; Parikh RT; Ross LV; Mazzaglia PJ; Foley C; Shin JJ; Mitchell JC; Berber E; Siperstein AE; Milas M
Surgery; 2011 Dec; 150(6):1102-12. PubMed ID: 22136828
[TBL] [Abstract][Full Text] [Related]
15. [Humoral mechanisms in neoplastic hypercalcemia].
Gennari C; Montagnani M; Nami R; Francini G
Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
[No Abstract] [Full Text] [Related]
16. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.
Brereton HD; Halushka PV; Alexander RW; Mason DM; Keiser HR; DeVita VT
N Engl J Med; 1974 Jun; 291(2):83-5. PubMed ID: 4835887
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of hypercalcemia in malignancy.
Besarab A; Caro JF
Cancer; 1978 Jun; 41(6):2276-85. PubMed ID: 657092
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyosarcoma-induced hypercalcemia in a nude mouse.
Takeuchi T; Takeuchi H; Hoshino R; Ohmi K
Cancer; 1982 Jul; 50(1):94-6. PubMed ID: 6952956
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia.
Budayr AA; Nissenson RA; Klein RF; Pun KK; Clark OH; Diep D; Arnaud CD; Strewler GJ
Ann Intern Med; 1989 Nov; 111(10):807-12. PubMed ID: 2817628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
